Find uplifting stories about heroes, innovations, and solutions
18775 results for "weight loss research"
New research challenges concerns that popular GLP-1 medications like Wegovy and Zepbound cause excessive muscle loss. The findings offer reassurance to millions considering or using these breakthrough weight-loss treatments.
Danish scientists discovered that losing weight doesn't just shrink fat cells—it actually helps regenerate healthier fat tissue. The breakthrough research shows that even modest weight loss can reverse obesity-related inflammation and restore fat tissue to a state resembling lean, healthy individuals.
A new weight-loss pill from AstraZeneca helped trial participants lose nearly 12% of their body weight in just nine months, offering fresh hope in the race to make weight management easier. The tablet could soon give doctors and patients another powerful tool in fighting obesity.
NIH researchers have discovered why popular weight loss drugs like Ozempic eventually stop working as well, and they've found a potential way to extend their effectiveness. The breakthrough could help millions push past frustrating plateaus.
Popular GLP-1 medications like Ozempic may improve testosterone levels and sperm quality in obese men, offering hope beyond weight loss. New research suggests these drugs could preserve fertility better than traditional testosterone therapy.
Postmenopausal women combining hormone therapy with a popular weight loss drug lost 35% more weight than those taking the medication alone. The finding could transform how millions of women manage weight gain after menopause.
German researchers have developed a breakthrough drug that outperformed popular weight-loss medications in early tests, targeting five body systems at once. The "quintuple agonist" could mean better results with fewer side effects, though human trials are still needed.
A breakthrough study shows the diabetes drug semaglutide helps older adults lose significant weight safely while improving heart health. Nearly half of participants over 65 achieved at least 15% weight loss in just over a year.
Breakthrough weight loss medications like Ozempic could help address rising obesity rates among people living with HIV in South Africa. Early research suggests these drugs work just as well for HIV patients as everyone else.
NIH researchers discovered why popular GLP-1 medications like Ozempic eventually stop working as well, and they found a possible solution. The breakthrough could help millions push past frustrating weight loss plateaus.
Breakthrough weight loss medications like Ozempic could help tackle rising obesity rates among people living with HIV in South Africa. Early research from rural KwaZulu-Natal shows these drugs work just as well for HIV patients as everyone else.
New research shows popular weight loss drugs like Wegovy help prevent heart attacks and heal liver disease even in people who don't lose pounds. This discovery could change how millions access life-saving treatment.
Researchers have created the first sex-specific brain map showing where popular weight-loss drugs like semaglutide work differently in females versus males. This breakthrough could explain why women often respond better to these treatments and pave the way for more personalized medicine.
New weight loss medications like Ozempic could help address obesity in people living with HIV, particularly black women who are disproportionately affected. Early research in South Africa is exploring how these breakthrough drugs might improve health outcomes for this community.
%2Fhttps%3A%2F%2Ftf-cmsv2-smithsonianmag-media.s3.amazonaws.com%2Ffiler_public%2Ff8%2Ff8%2Ff8f86afc-d21d-40cc-86c9-e212d1e51222%2Fleslie_leinwand_snake_research_0181.jpg)
Scientists discovered an appetite-suppressing molecule in python blood that helped obese mice lose 9% of their body weight without the stomach problems that plague current weight-loss drugs. This breakthrough could lead to a new generation of treatments inspired by nature's most extreme fasters.
Popular weight-loss medications like Ozempic may dramatically slow the spread of certain cancers, according to groundbreaking research from Cleveland Clinic. The study found up to 50% lower progression rates for four major cancer types among patients taking these drugs.
People using GLP-1 weight loss medications may not need weekly injections forever. A new study shows many patients maintain their weight loss while spacing out doses to every two or even six weeks.
Danish researchers found that popular GLP-1 drugs like semaglutide reduced asthma flare-ups by a quarter and cut inhaler dependence by 14%. The breakthrough suggests these medications do more than just help with weight loss.
A groundbreaking UCLA study of nearly 94,000 diverse patients discovered how genetics predict who responds best to popular weight loss medications like Ozempic. This breakthrough could transform how doctors prescribe treatments, ensuring medications work better for everyone.
A tiny molecule discovered using AI mimics Ozempic's weight loss effects without the nausea, constipation, or muscle loss. Animal studies show the peptide targets only the brain's appetite center, not the entire digestive system.
Showing 20 of 18775